Menu
Back to User profile » Prof. Dr. João Beirão
Papers published by Prof. Dr. João Beirão:
Scheimpflug-Based Corneal Biomechanical Analysis As A Predictor of Glaucoma in Eyes With High Myopia
Baptista PML, Ferreira AS, Silva NP, Figueiredo ARM, Sampaio IC, Reis RVF, Ambrósio R Jr, Menéres PMAM, Beirão JNM, Menéres MJFS
Clinical Ophthalmology 2024, 18:545-563
Published Date: 22 February 2024
Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives
Marques JH, Coelho J, Menéres MJ, Melo Beirão J
Clinical Ophthalmology 2022, 16:2227-2233
Published Date: 9 July 2022
Corneal Biomechanics for Ocular Hypertension, Primary Open-Angle Glaucoma, and Amyloidotic Glaucoma: A Comparative Study by Corvis ST
Silva N, Ferreira A, Baptista PM, Figueiredo A, Reis R, Sampaio I, Beirão J, Vinciguerra R, Menéres P, Menéres MJ
Clinical Ophthalmology 2022, 16:71-83
Published Date: 8 January 2022
Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
Pessoa B, Marques JH, Leite J, Silva N, José D, Coelho C, Figueira J, Meireles A, Melo-Beirão JN
Clinical Ophthalmology 2021, 15:4081-4090
Published Date: 9 October 2021
Corneal Biomechanical Assessment with Ultra-High-Speed Scheimpflug Imaging During Non-Contact Tonometry: A Prospective Review
Baptista PM, Ambrosio R Jnr, Oliveira L, Meneres P, Beirao JM
Clinical Ophthalmology 2021, 15:1409-1423
Published Date: 6 April 2021
Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine–Gass Syndrome
Marques JH, Abreu AC, Silva N, Meireles A, Pessoa B, Melo Beirão J
International Medical Case Reports Journal 2021, 14:127-132
Published Date: 26 February 2021
Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
Pessoa B, Malheiro L, Carneiro I, Monteiro S, Coelho J, Coelho C, Figueira J, Meireles A, Melo Beirão JN
Clinical Ophthalmology 2021, 15:253-260
Published Date: 22 January 2021
Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)
Pessoa B, Melo-Beirão J, Meireles A, Menéres P
International Medical Case Reports Journal 2020, 13:437-448
Published Date: 15 September 2020
Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
Coelho J, Malheiro L, Melo Beirão J, Meireles A, Pessoa B
Clinical Ophthalmology 2019, 13:1751-1759
Published Date: 9 September 2019